Etravirine as a culprit of recurrent drug-eluting in-stent restenosis in an HIV patient.
The Department of Internal Medicine, Mercy Hospital and Medical Center, Chicago, IL, United States. Electronic address: gauravsk6@yahoo.com.
Gaurav K
GK
Sharma
The Department of Internal Medicine, Mercy Hospital and Medical Center, Chicago, IL, United States.
Michael
M
Megaly
D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D004347:Drug Interactions / Q000502:physiology; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D008875:Middle Aged; D009570:Nitriles; D011724:Pyridazines / Q000009:adverse effects* / Q000097:blood; D011743:Pyrimidines; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use
D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine; D000077144:Clopidogrel; D013988:Ticlopidine
Clopidogrel; Coronary artery disease; Etravirine; HIV; In-stent restenosis